Skip to main content
Caplight Logo









Conmind Medical

Conmind Medical

Private
ShenzhenHealthcare & Life Scienceshttps://www.conmindmed.com/

Last Round

VC Round

Oct 20, 2025

Total Funding Raised

$42.1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Conmind is a medical device company that develops solutions for neurointervention and structural heart disease, and is expanding into brain-computer interface technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

interventional medical devicesmedtechneurointervention devicesstructural heart devicesmedical device manufacturingneurovascular interventionstructural heart interventiontranscatheter mitral valve repairPFO closure systemflow divertercoil embolization systemstentscathetersembolic protection systembrain-machine interface

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Conmind Medical Comparables

Compare Conmind Medical with similar companies based on industry and business-model similarity.

Conmind Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NeuroSafe Medical Co., Ltd.
83%
APT Medical Inc.
81%
Peijia Medical
80%

Conmind Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 20, 2025
GrantJan 6, 2022

Conmind Medical Investors

Notable investors and investment history

Conmind Medical investors
InvestorRounds
Backed VCSeed, VC Round, Series A
Thiel FoundationGrant
Angelini VenturesVC Round, Series A
Phoenix Court GroupSeed, VC Round, Series A
PluralVC Round
Entrepreneurs FirstSeed, VC Round, Series A
Octopus VenturesVC Round, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 20, 2025

    $60M raised, led by Plural.

  • Jan 6, 2022

    $100K grant from Thiel Foundation

Conmind Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Conmind Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Conmind Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Employee Range7
Year Founded2020
Last FundingOct 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?